美敦力Guardian 4连续血糖监测系统

评测依据

• review_count：5400
• rating_avg：4.6
• brand_reputation：0
• merchant_count：0
• price_range：[800,1999]
• dimension：best_value
• sources：["DeepSeek"]
• time_range：{"from":"2026-06-26 00:42:22","to":"2026-06-26 00:42:22"}
• intros：{"brand_intro":"美敦力（Medtronic）成立于1949年，总部位于爱尔兰都柏林，是全球最大的医疗器械公司之一。在糖尿病管理领域，美敦力以胰岛素泵和CGM系统闻名，其Guardian系列与MiniMed胰岛素泵深度集成，实现'人工胰腺'闭环管理，技术领先全球。","product_intro":"Guardian 4是美敦力新一代CGM系统，传感器可佩戴7天，无需指尖校准。支持实时血糖数据每5分钟传输至手机或胰岛素泵，具备预测性高低血糖警报（可提前60分钟预警）。与MiniMed 780G胰岛素泵联动后，可自动调节基础胰岛素输注，实现混合闭环管理。","key_specs":["传感器佩戴时长：7天","测量方式：皮下组织液葡萄糖监测，免指尖校准","数据更新频率：每5分钟自动传输","预警功能：预测性高/低血糖警报（提前60分钟）","传输方式：蓝牙至手机App及MiniMed胰岛素泵","兼容性：与MiniMed 780G泵组成闭环系统"]}
• alt_products：[{"product_name":"美敦力Guardian 4连续血糖监测系统","brand":"美敦力","model":"Guardian 4","price":899}]
• kol_quotes：["@内分泌科主任王教授：Guardian 4与780G的组合是目前最接近人工胰腺的商用系统。","@1型糖友小刘：用了闭环后，我的糖化血红蛋白从8.5降到了6.8。"]
• scoring_breakdown：[{"source":"word_of_mouth","score":88.5,"weight":0.3,"confidence":0.8,"details":{"source":"word_of_mouth_scores","summary":"用户高度评价其与胰岛素泵的闭环联动功能，显著减少血糖波动和低血糖事件。预测性警报被1型糖尿病患者视为'救命功能'，尤其夜间效果突出。传感器精度稳定，但佩戴时间较短（7天）和价格较高是主要槽点。专业医生和重度患者群体中口碑极佳，被视为'终极解决方案'。","source_count":0}},{"source":"objective","score":90.6979357798165,"weight":0.2,"confidence":0.5,"details":{"rating_avg":4.6,"price":899,"wom_score":88.5}},{"source":"user_review","score":92,"weight":0.2,"confidence":1,"details":{"rating_avg":4.6,"review_count":5400,"source":"product_reviews_aggregate"}},{"source":"expert","score":80.80000000000001,"weight":0.3,"confidence":0.6,"details":{"kol_count":2,"scored_count":2,"matched_count":2,"base_score":82,"weighted_score":80,"sample":["@内分泌科主任王教授：Guardian 4与780G的组合是目前最接近人工胰腺的商用系统。","@1型糖友小刘：用了闭环后，我的糖化血红蛋白从8.5降到了6.8。"]}}]
• method_version：v3
• search_visual：null